Innovation translates into antidepressant effectiveness.
Unipolar depression is a major cause of disability in developed societies. There is significant unmet need because existing treatments are neither as effective nor as free of adverse effects as we would hope. Agomelatine is a new antidepressant with a novel profile of pharmacological action. Its eff...
| Huvudupphovsman: | |
|---|---|
| Materialtyp: | Journal article |
| Språk: | English |
| Publicerad: |
2008
|